Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* known allergic reactions to the study medication or any component of the product. * active bacterial, viral, tb, fungal infectious diseases * received immunosuppressant or immunomodulatory in the past 30 days * neutrophil count \< 500 cells/microliter * platelets \< 50,000/microliter * pregnant or breastfeeding females	* known allergic reactions to the study medication or any component of the product. * active bacterial, viral, tb, fungal infectious diseases * received immunosuppressant or immunomodulatory in the past 30 days * neutrophil count \< 500 cells/microliter * platelets \< 50,000/microliter * pregnant or breastfeeding females
Nov. 27, 2020, 12:31 a.m.	usa	- known allergic reactions to the study medication or any component of the product. - active bacterial, viral, tb, fungal infectious diseases - received immunosuppressant or immunomodulatory in the past 30 days - neutrophil count < 500 cells/microliter - platelets < 50,000/microliter - pregnant or breastfeeding females	- known allergic reactions to the study medication or any component of the product. - active bacterial, viral, tb, fungal infectious diseases - received immunosuppressant or immunomodulatory in the past 30 days - neutrophil count < 500 cells/microliter - platelets < 50,000/microliter - pregnant or breastfeeding females